Stanford Human Systems Immunology Center

Mark M. Davis, PhD, Director, Stanford Human Systems Immunology Center

Harnessing the immune system to develop vaccines against the world's deadliest infectious diseases

The Stanford Human Systems Immunology Center was established in January 2015 with a grant from the Bill and Melinda Gates Foundation (BMGF). The $50 million grant over 10 years builds on existing technology developed at Stanford and housed in the Human Immune Monitoring Core. The center aims to better understand how the immune system can be harnessed to develop vaccines for the world’s most deadly infectious diseases.

The work funded through the center enables researchers in diverse fields of study at Stanford and other institutions to use advanced immunological tools to understand how vaccines protect and to help prioritize the most promising vaccines for clinical trials.

Our work complements the work being done by other BMGF partners to address major global health problems and provides an avenue for accelerating the development of effective vaccines in order to deepen our understanding of disease pathogenesis and mechanisms of resistance.

Learn more about our goals.

Pilot Project Funding Opportunity

What: Internal Stanford grant opportunity ranging from $50,000 - $200,000 per year for two years for pilot projects.